Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions
The S&P 500 (^GSPC 1.33%) fell 1.33% to 6,740.02, the Nasdaq Composite (^IXIC 1.59%) slid 1.59% to 22,387.68, and the Dow Jones Industrial Average (^DJI 0.95%) dropped 0.95% to 47,501.55 as a weak jobs report and surging oil reinforced risk-off sentiment.
Market movers
Energy stocks were rare gainers, with Diamondback Energy (FANG +0.95%) up about 0.84% as crude reached $91, while growth names lagged; smaller-cap biotech Day One Biopharmaceuticals (DAWN +65.88%) bucked the sell-off on a buyout deal with independent international pharmaceutical group Servier.
What this means for investors
The day started on a down note after the Bureau of Labor Statistics reported that U.S. payrolls shrank by 92,000 and unemployment rose 10 basis points to 4.4% in February. At the same time, the ongoing conflict in the Middle East pushed oil over $90.
That combination has investors concerned that an environment of stagflation may be upon us. That helped drive energy stocks higher, but most other equities were in negative territory.
Oil experienced its largest weekly increase since 2020 due to concerns over potential disruptions near the Strait of Hormuz. While this development boosts producers, it is negatively impacting nearly every other sector in the S&P 500 as investors reevaluate the duration of sustained inflation.
On the positive side, acquisition news today pushed Day One Biopharmaceuticals stock 66% higher. The biotech company focused on creating and marketing targeted therapies for individuals with life-threatening illnesses will be taken over for $21.50 per share in cash, amounting to a total equity value of around $2.5 billion.